The combination of low-dose rituximab and steroids was linked to overall response rates of more than 80% in a cohort of patients with autoimmune hemolytic anemia, according to recent results. Low-dose ...

Autoimmune hemolytic anemia (AIHA) and paroxysmal nocturnal hemoglobinuria (PNH) are distinct blood disorders with different underlying causes and treatment approaches. Each is rare and potentially ...

Cold antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by autoantibodies at temperatures of approximately 0 to 10 degrees Celsius. Q ...

No data regarding hemolytic complications after double UCBT are available in the literature. We report a case of combined auto- and alloimmune hemolysis after double UCBT that proved fatal. A ...

The following report presents 3 cases of intravascular hemolysis that followed aortic-valve replacement with cusps composed of Dacron cloth impregnated with silicone rubber. 8,9 Hematologic data on 32 ...

The FDA approved mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. Pyruvate kinase (PK) deficiency is a rare inherited disorder that causes anemia via the ...

SOUTH SAN FRANCISCO, Calif., March 8, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the publication of data in the American Journal of Hematology from the open label, ...

THE absence of anemia in infectious mononucleosis is generally accepted. Indeed, this fact is useful as an aid in the differential diagnosis of infectious mononucleosis and leukemia. Bernstein 1 has ...

Enjaymo is the first-and-only approved therapeutic option approved for hemolytic anemia in adult patients with cold agglutinin disease Chief Medical Officer, Global Head of Development at Sanofi “This ...